Clinical Trials in Philadelphia

Showing 9941-9960 of 20,904 trials

USCRI READY4Life Program

NCT05476185

The U.S. Committee for Refugees and Immigrants (USCRI) has developed the Relationships, Education, Advancement, and Development for Youth for Life (READY4Life) Program. This is a 16-hour program for immigrants/refugees, ages 14 to 24. The program is designed to help young immigrants and refugees prepare for a successful life in the United States. The program is taught by USCRI program staff and is being implemented at eight sites across the U.S.: Cleveland, Ohio; Colchester, Vermont; Des Moines, Iowa; Miami, Florida; Philadelphia, Pennsylvania; Raleigh, North Carolina; Saint Paul, Minnesota; and Twin Falls, Idaho. The project also includes a rigorous evaluation component, featuring a Randomized Control Trial (RCT) design.

CommunicationProblem SolvingSocial Relationships+1 more

US Committee for Refugees and Immigrants4,800 participantsStarted Feb 2022

Washington D.C., District of Columbia, United States • Miami, Florida, United States • Twin Falls, Idaho, United States +6 more locations

TERMINATEDPhase 1/2< 1 mile

A Safety and Efficacy Study of Carfilzomib and Pomalidomide With Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

NCT01464034

This is a dose finding pilot study to evaluate the safety and determine the maximum tolerated dose of the combination of carfilzomib and pomalidomide with dexamethasone (CPD) in patients with relapsed or refractory multiple myeloma followed by a phase II expansion at the MTD to evaluate efficacy.

Multiple Myeloma

Criterium, Inc.136 participantsStarted Nov 2011

Atlanta, Georgia, United States • Indianapolis, Indiana, United States • Hackensack, New Jersey, United States +6 more locations

USCRI READY4Life Program

A Safety and Efficacy Study of Carfilzomib and Pomalidomide With Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

Find Trials by Condition in Philadelphia

Therapy for High-Risk HPV 16-Positive Oropharynx Cancer Patients

A Study To Assess The Tolerability And Clinical Activity Of Gedatolisib In Combination With Palbociclib/Letrozole Or Palbociclib/Fulvestrant In Women With Metastatic Breast Cancer

ET-01 in Subjects With Lateral Canthal Lines, LCL-209

Propranolol for Protracted Labor

Efficacy and Safety of Human Plasma-derived C1-esterase Inhibitor as add-on to Standard of Care for the Treatment of Refractory Antibody Mediated Rejection (AMR) in Adult Renal Transplant Recipients

Remote Wheelchair Skills Training Efficacy

Differin® Gel x12 Wks vs Tazorac® Cream x12 Wks vs Differin® x6 Wks Switched to Tazorac® x6 Wks for Treatment of Acne

Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle

Interventional Validation of an MDS-Specific Measure of Quality of Life: Assessing the Responsiveness of the Quality of Life in Myelodysplasia Scale (QUALMS-1) to Different Hypomethylating Agent Regimens for Low and Intermediate Risk Disease

A Study of FOR46 in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)

Efficacy and Safety of AXA1665 in Cirrhotic Subjects With Prior Overt Hepatic Encephalopathy

Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Erosive Esophagitis

Respiratory Syncytial Virus (RSV) Investigational Vaccine in Infants Aged 6 and 7 Months Likely to be Unexposed to RSV

Phase 2 Safety and Efficacy Study of Zilucoplan (RA101495) to Treat PNH Patients Who Have an Inadequate Response to Eculizumab

A Clinical Assessment Study in X-Linked Myotubular Myopathy (XLMTM) Subjects

Efficacy and Safety of Orally Administered DS102 in Patients With Acute Alcoholic Hepatitis

Tissue Collection for Correlation Between ATM Alterations by Next-Generation Sequencing and ATM Loss-of-Protein

Prone Positioning Short-term Effects on Tissue Oxygen Saturation in Critical COVID-19 Patients